Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Other Non Operating Income (2016 - 2025)

Exicure's (XCUR) quarterly Other Non Operating Income came in at $127000.0 in Q4 2025, up 370.37% on a QoQ basis from $27000.0 in Q3 2025.

Exicure (XCUR) Other Non Operating Income (2016 - 2025) Analysis & Trends

Exicure (XCUR) has 10 years of Other Non Operating Income data on file, last reported at $127000.0 in Q4 2025.

  • Quarterly Other Non Operating Income changed N/A year-over-year to $127000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $206000.0 (down 90.45% YoY) and the FY2025 annual result came in at $107000.0, up 2040.0% from the prior year.
  • Other Non Operating Income rose to $127000.0 in Q4 2025, from $27000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.5 million in Q3 2024 to a low of -$150000.0 in Q2 2023.
  • A 5-year average of $123105.3 and a median of $7000.0 in 2023 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2023 — Other Non Operating Income plunged 3650.0% — and 2024, when it surged 1548.35%.
  • Tracing XCUR's Other Non Operating Income over 5 years: stood at $3000.0 in 2021, then slumped by 3400.0% to -$99000.0 in 2022, then soared by 107.07% to $7000.0 in 2023, then soared by 21328.57% to $1.5 million in 2024, then tumbled by 91.53% to $127000.0 in 2025.
  • The last three Other Non Operating Income figures came in at $127000.0 (Q4 2025), $27000.0 (Q3 2025), and $52000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Exicure 7.27 Mn 7.27 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 127,000.00
Sep 30, 2025 27,000.00
Jun 30, 2025 52,000.00
Mar 31, 2025 27,000.00
Sep 30, 2024 1.50 Mn
Jun 30, 2024 631,000.00
Mar 31, 2024 4,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 91,000.00
Jun 30, 2023 -150,000.00
Mar 31, 2023 104,000.00
Dec 31, 2022 -99,000.00
Sep 30, 2022 41,000.00
Jun 30, 2022 -4,000.00
Mar 31, 2022 -20,000.00
Dec 31, 2021 3,000.00
Sep 30, 2021 -5,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 1,000.00
Dec 31, 2020 51,000.00